Good evening :)
$
₹
Stryker Corporation

Stryker Corporation

SYK

NYSE
Asset Logo

Stryker Corporation

SYK

NYSE
$339.859.43% (+29.30)
$
₹
$339.859.43% (+29.30)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $118.2B the stock is ranked 144

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

32.68
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

5.01
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$9.5
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.43
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

13.78%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1.15%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 30 analysts reports

Buy
23 analysts
Hold
7 analysts
Sell
0 analyst

Price Upside

+0.25%

Earnings Growth

+8.83%

Rev. Growth

+6.75%

See Detailed Forecast

Company Profile

Company Profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
40.97
40.97
1Y Return
13.03%
13.03%
Buy Reco %
82.14
82.14
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.09
38.09
1Y Return
7.61%
7.61%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
53.29
53.29
1Y Return
10.52%
10.52%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
24.41
24.41
1Y Return
16.08%
16.08%
Buy Reco %
66.66
66.66
Boston Scientific Corp
BSX
Boston Scientific Corp
P/E Ratio
18.35
18.35
1Y Return
55.98%
55.98%
Buy Reco %
67.74
67.74
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 0.25% growth, versus a trailing 3-year CAGR of 7.72%.

2026
Current$339.65Baseline
Analyst Target - 1 year
Target$340.48+0.25%

All values in $

202220232024202520262027$259.05$303.83$348.62Target+0.25%
2026
Current$339.65Baseline
Analyst Target - 1 year
Target$340.48+0.25%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 6.75% growth, versus a trailing 3-year CAGR of 10.83%.

2025
Current$25.11Baseline
Forecast for Dec 2026
High$26.90+7.11%
Average$26.81+6.75%
Low$26.70+6.31%

All values in $ Billion

20212022202320242025202617.1018.4420.4922.5925.11Low+6.31%Average+6.75%High+7.11%
2025
Current$25.11Baseline
Forecast for Dec 2026
High$26.90+7.11%
Average$26.81+6.75%
Low$26.70+6.31%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 8.83% growth, versus a trailing 3-year CAGR of 13.43%.

2025
Current$13.63Baseline
Forecast for Dec 2026
High$14.88+9.17%
Average$14.83+8.83%
Low$14.8+8.58%

All values in $

2021202220232024202520269.099.3410.612.1913.63Low+8.58%Average+8.83%High+9.17%
2025
Current$13.63Baseline
Forecast for Dec 2026
High$14.88+9.17%
Average$14.83+8.83%
Low$14.8+8.58%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

7.1
0.8
6
0.7
6.5
1.2
6.5
0.7
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue5.425.496.435.866.026.057.176.026.586.52
Net Income0.820.830.540.650.880.850.840.741.270.75
Net Profit Margin15.21%15.18%8.48%11.14%14.67%14.18%11.83%12.37%19.36%11.54%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Stryker Corporation 32.685.011.43
Abbott Laboratories40.973.721.57
Danaher Corporation38.092.981.29
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare SYK with any stock or ETF
Compare SYK with any stock or ETF
Comparing from
SYK
ABT
DHR
Loading...

Frequently asked questions

  1. Stryker Corporation (SYK) share price today is $339.85 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $342.59 and a day low of $326.87.

  2. Stryker Corporation stock trades on NYSE under the ticker symbol SYK.

  3. Stryker Corporation's market capitalization is $118.22B as of November 5, 2026 at 2:29 AM IST.

  4. Stryker Corporation's price-to-earnings (P/E) ratio is 32.68 as of November 5, 2026.

  5. Stryker Corporation's price-to-book (P/B) ratio is 5.01 as of November 5, 2026.

  6. Yes, Stryker Corporation pays a dividend, with a current dividend yield of 1.15%.

  7. Yes, You can buy Stryker Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Stryker Corporation shares in three steps: 1. Search Stryker Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Stryker Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Stryker Corporation (SYK) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0294 shares at the current price of $339.85.

Loading...